发明公开
- 专利标题： NOVEL ANTI-PAD4 ANTIBODY
-
申请号： US18546981申请日： 2022-02-18
-
公开(公告)号： US20240309112A1公开(公告)日： 2024-09-19
- 发明人: Yuya MIYAMOTO , Koichi WADA , Yuichi IMURA , Kenji SAITO , Tomoko SAKATA , Takanari SHIGEMITSU
- 申请人： MITSUBISHI TANABE PHARMA CORPORATION , PHARMA FOODS INTERNATIONAL CO., LTD.
- 申请人地址： JP Osaka-shi
- 专利权人： MITSUBISHI TANABE PHARMA CORPORATION,PHARMA FOODS INTERNATIONAL CO., LTD.
- 当前专利权人： MITSUBISHI TANABE PHARMA CORPORATION,PHARMA FOODS INTERNATIONAL CO., LTD.
- 当前专利权人地址： JP Osaka-shi; JP Kyoto-shi
- 优先权： JP 21024642 2021.02.18
- 国际申请： PCT/JP2022/006528 2022.02.18
- 进入国家日期： 2023-08-18
- 主分类号： C07K16/40
- IPC分类号： C07K16/40 ; A61K39/00 ; A61P19/02 ; A61P37/06
摘要：
Provided is an anti-PAD4 antibody or an antibody fragment thereof, wherein HCDR1 comprises an amino acid sequence of SEQ ID NO: 1, HCDR2 comprises an amino acid sequence of SEQ ID NO: 2, HCDR3 comprises an amino acid sequence of SEQ ID NO: 3, LCDR1 comprises an amino acid sequence of SEQ ID NO: 4, LCDR2 comprises an amino acid sequence of SEQ TD NO: 5, and LCDR3 comprises an amino acid sequence of SEQ ID NO: 6.
信息查询
